Bidirectional Prospective Associations of Metabolic Syndrome Components With Depression, Anxiety, and Antidepressant Use

Abstract

BackgroundMetabolic syndrome components—waist circumference, high‐density lipoprotein cholesterol (HDL‐C), triglycerides, systolic blood pressure and fasting glucose—are cross‐sectionally associated with depression and anxiety with differing strength. Few studies examine the relationships over time or whether antidepressants have independent effects.MethodsParticipants were from the Netherlands Study of Depression and Anxiety (NESDA; N = 2,776; 18–65 years; 66% female). At baseline, 2‐ and 6‐year follow‐up, participants completed diagnostic interviews, depression and anxiety symptom inventories, antidepressant use assessment, and measurements of the five metabolic syndrome components. Data were analyzed for the consistency of associations between psychopathology indicators and metabolic syndrome components across the three assessment waves, and whether psychopathology or antidepressant use at one assessment predicts metabolic dysregulation at the next and vice versa.ResultsConsistently across waves, psychopathology was associated with generally poorer values of metabolic syndrome components, particularly waist circumference and triglycerides. Stronger associations were observed for psychopathology symptom severity than diagnosis. Antidepressant use was independently associated with higher waist circumference, triglycerides and number of metabolic syndrome abnormalities, and lower HDL‐C. Symptom severity and antidepressant use were associated with subsequently increased number of abnormalities, waist circumference, and glucose after 2 but not 4 years. Conversely, there was little evidence that metabolic syndrome components were associated with subsequent psychopathology outcomes.ConclusionsSymptom severity and antidepressant use were independently associated with metabolic dysregulation consistently over time and also had negative consequences for short‐term metabolic health. This is of concern given the chronicity of depression and anxiety and prevalence of antidepressant treatment.

The relationship between chronic physical conditions, multimorbidity and anxiety in the general population: A global perspective across 42 countries

“…However, a number of hypotheses have been proposed for the increased risk of physical conditions in people with anxiety including psychotropic medication use [40], biological risk factors such as an increased inflammatory profile, including increased levels of C-reactive protein and interleukin-6 [41] and hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation [42]. Moreover, a stress response may contribute to the pathophysiology of both, anxiety and several chronic conditions [43].…”

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities

“…There is a vast pathophysiological overlap between obesity, T2DM, and depression, with bidirectional relationships being consistently reported [113,114] . These disorders also share common risk factors such as poor diet and physical inactivity [115,116] .…”

Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up

“…Several psychiatric disorders, such as schizophrenia (6), bipolar disorder (7), and depressive disorder (8), have been consistently associated with an increased risk of metabolic and cardiovascular complications, which in turn are thought to contribute to the markedly increased mortality rates associated with these conditions (9,10). The mechanisms by which patients with mental disorders are more prone to developing MetS are complex (11), but factors related to lifestyle choices, such as smoking, a poor diet, and the absence of physical activity (12), as well as the prolonged use of psychiatric medication, particularly antipsychotics (13) and some antidepressants (14)(15)(16)(17)(18), have been described as relevant contributors to the risk.…”